Best Immunotherapy For Kidney Cancer Doctors in Istanbul for Australians

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

The doctor graduated from the School of Medicine at Hacettepe University and completed residency at Istanbul Sisli Etfal Training and Research Hospital, followed by a fellowship at the Hacettepe University Cancer Institute.

Specializing in oncology, the doctor has extensive experience in treating various cancers, including breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers.

The doctor has worked at prestigious institutions such as The University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital with specialist expertise in managing complex gastrointestinal and genitourinary malignancies.

• Holds a professorship in medical oncology from one of Turkey's leading medical institutions
• Completed specialised training in hemodialysis at Cerrahpasa Medical Faculty
• Active member of the American Society of Clinical Oncology (ASCO)
• Maintains professional standing with the European Neuroendocrine Tumour Society (ENET)
• Fellowship trained at the Istanbul University Oncology Institute

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Yesim Yildirim is a medical oncologist at Anadolu Medical Center. She specializes in immunotherapy and targeted therapy for breast, lung, and gastrointestinal cancers. Dr. Yildirim is ESMO-certified and holds the rank of Professor. She completed training at Mount Vernon in the UK and Rambam Medical Center.

• Authored over 80 scientific publications on tumor biology and precision medicine.
• Treats complex cases including melanoma, sarcomas, and stage 4 lung cancer.
• Member of ASCO and the International Society of Gastrointestinal Oncology.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Hospital.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Professor Sezer Saglam leads the Medical Oncology Department at Istanbul Florence Nightingale Hospital with a focus on targeted cancer therapies.

• Holds a professorship in medical oncology from one of Turkey's top medical institutes
• Specialises in gastrointestinal oncology and complex tumour management
• Member of the European Society for Medical Oncology (ESMO)
• Trained in hemodialysis at Cerrahpasa Medical Faculty to manage patient renal health
• Member of the American Society of Clinical Oncology (ASCO)

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Ercan Ozden serves as a medical oncology specialist at VM Medical Park Pendik Hospital, specialising in internal medicine and complex cancer therapies.

• Completed an English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Broad residency training in internal medicine at a leading Turkish university hospital
• Highly specialised subspecialty training in medical oncology from Kocaeli University
• Works within the JCI-accredited Medical Park network providing evidence-based protocols

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in complex cancer care and advanced immunotherapy protocols.

• Completed a dedicated fellowship in Allergy and Immunology, providing deep expertise in how the immune system interacts with cancer treatments
• Published specific research on outcomes for metastatic renal cell carcinoma and urothelial tumours
• Served as a sub-investigator for major international clinical trials with Roche, Pfizer, and AstraZeneca
• Holds ESMO Board Certification in Medical Oncology, an internationally recognised standard of excellence

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acıbadem Regional Hospital with a specialist focus on immunotherapy and targeted therapies for solid tumours.

• Serves on the Editorial Board for BMC Cancer, a respected international medical journal
• Published over 50 scientific articles on advanced cancer treatments and patient outcomes
• Full member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Specialises in managing cancer-related malnutrition and cachexia alongside oncology treatments

Associate Professor Ayse Irem Yasin holds an ESMO Board Certificate from Paris, a prestigious recognition of expertise in modern cancer protocols. She currently treats oncology patients at Medipol Acıbadem District Hospital.

• Specialises in urological cancers, including complex kidney cancer cases
• Completed clinical observerships at the Cleveland Clinic and Harvard Medical School
• Expert in managing adenocarcinomas using precision systemic therapies
• Focuses on the latest immunotherapy applications for various solid tumours

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı with a prolific research background in advanced cancer markers.

• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Serves as the Education Coordinator for the Medical Oncology Sub-Branch
• Published 19 peer-reviewed studies on biomarkers and treatment survival outcomes
• Specialises in managing complex metastatic cases using evidence-based protocols
• Expertise in interpreting molecular and genomic profiles to guide therapy choices

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
Autologous bone marrow mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male infertility, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Stem Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​